Old Web
English
Sign In
Acemap
>
Paper
>
Impact of regorafenib in the clinical practice and identification of second-line treatment orphan patients
Impact of regorafenib in the clinical practice and identification of second-line treatment orphan patients
2018
Marco Sanduzzi Zamparelli
V. Sapena
Álvaro Díaz-González
Anna Darnell
N. Llarch
Ernest Belmonte
Loreto Boix
G. Iserte
Alejandro Forner
J. Corominas
L.G. Da Fonseca
C. Ayuso
Jordi Bruix
María Reig
Keywords:
Virology
Clinical Practice
Regorafenib
Physical therapy
Medicine
second line treatment
Diabetes mellitus
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]